NL-OMON36697已完成2 期
Prevention of the progression of very early symptoms into ankylosing spondylitis - PREVAS
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients to be included must meet the following criteria.
- •- age * 18 years,
- •- patient with inflammatory back pain for at least 3 months, with onset < 45 years
- •- presence of ³2 SpA-features or
- •- presence of ³1 SpA-feature with HLA-B27 positivity or two family members with definite AS (1e or 2e degree family-member);
- •- no definite sacroiliitis on the X-ray (sacroiliitis grade 1 is sustained);
- •- BASDAI score of * 4 (0-10)
- •- Insufficient response to treatment with NSAID's over a 4-week period
排除标准
- •- definite AS (modified New York criteria (9);
- •- previous treatment with TNF-blockers.
- •General medical exclusion criteria: for treatnebt with TNF blockers (pregnancy or planning pregnancy, infections, tuberculosis, HIV, Hepatitis B or C, malignincies etc)
研究者
相似试验
进行中（未招募）
不适用
PREVENTION OF THE PROGRESSION OF VERY EARLY SYMPTOMSINTO ANKYLOSING SPONDYLITIS: A PLACEBO CONTROLLED TRIAL WITH ETANERCEPT - PREVASEUCTR2009-015515-40-NLWyeth Pharmaceuticals B.V.80
尚未招募
不适用
PREVAS: prevention of ankylosing spondylitis.ankylosing spondylitis, inflammatory back pain, morning stiffness, chronic (low) back pain, arthiritis, buttock pain, dactylitis, enthestitis, psoriasis, non-gonococcal urethritis or cercvicitisNL-OMON29047investigator drive study supported by Wyeth80
已完成
不适用
Prodromal symptoms and early intervention to prevent a relapseSchizophreniaISRCTN17350364Mental Health Care Services Drenthe (Netherlands)147
招募中
不适用
Pre-frail New efforts to prevent the progression of frail by intervention of agarooligosaccharides in the elderlyfrailJPRN-UMIN000046285Matsumoo university30
进行中（未招募）
不适用
Assessing the effectiveness of a mindfulness psychoeducation programme at preventing physical and psychological symptoms among cancer survivorsAlleviation of negative physical and psychological symptoms for cancer survivorsSigns and SymptomsISRCTN10756993ational University of Singapore210